Figure 1 (Winrevair 01)
This text contains detailed information about a clinical trial evaluating the effectiveness of WINREVAIR versus Placebo in patients with different subgroups related to PAH Diagnosis Group, Congenital heart disease, WHO Functional Class, Baseline PVR levels, and various other parameters for analysis. The study also includes data on Prostacyclin infusion therapy at baseline and background therapy.*